12 research outputs found

    PLoS Med

    Get PDF
    Background In 2014, the government of Togo implemented a pilot unconditional cash transfer (UCT) program in rural villages that aimed at improving children’s nutrition, health, and protection. It combined monthly UCTs (approximately US$8.40 /month) with a package of community activities (including behavior change communication [BCC] sessions, home visits, and integrated community case management of childhood illnesses and acute malnutrition [ICCM-Nut]) delivered to mother–child pairs during the first “1,000 days” of life. We primarily investigated program impact at population level on children’s height-for-age z-scores (HAZs) and secondarily on stunting (HAZ < −2) and intermediary outcomes including household’s food insecurity, mother–child pairs’ diet and health, delivery in a health facility and low birth weight (LBW), women’s knowledge, and physical intimate partner violence (IPV). Methods and findings We implemented a parallel-cluster–randomized controlled trial, in which 162 villages were randomized into either an intervention arm (UCTs + package of community activities, n = 82) or a control arm (package of community activities only, n = 80). Two different representative samples of children aged 6–29 months and their mothers were surveyed in each arm, one before the intervention in 2014 (control: n = 1,301, intervention: n = 1,357), the other 2 years afterwards in 2016 (control: n = 996, intervention: n = 1,035). Difference-in-differences (DD) estimates of impact were calculated, adjusting for clustering. Children’s average age was 17.4 (± 0.24 SE) months in the control arm and 17.6 (± 0.19 SE) months in the intervention arm at baseline. UCTs had a protective effect on HAZ (DD = +0.25 z-scores, 95% confidence interval [CI]: 0.01–0.50, p = 0.039), which deteriorated in the control arm while remaining stable in the intervention arm, but had no impact on stunting (DD = −6.2 percentage points [pp], relative odds ratio [ROR]: 0.74, 95% CI: 0.51–1.06, p = 0.097). UCTs positively impacted both mothers’ and children’s (18–23 months) consumption of animal source foods (ASFs) (respectively, DD = +4.5 pp, ROR: 2.24, 95% CI: 1.09–4.61, p = 0.029 and DD = +9.1 pp, ROR: 2.65, 95% CI: 1.01–6.98, p = 0.048) and household food insecurity (DD = −10.7 pp, ROR: 0.63, 95% CI: 0.43–0.91, p = 0.016). UCTs did not impact on reported child morbidity 2 week’s prior to report (DD = −3.5 pp, ROR: 0.80, 95% CI: 0.56–1.14, p = 0.214) but reduced the financial barrier to seeking healthcare for sick children (DD = −26.4 pp, ROR: 0.23, 95% CI: 0.08–0.66, p = 0.006). Women who received cash had higher odds of delivering in a health facility (DD = +10.6 pp, ROR: 1.53, 95% CI: 1.10–2.13, p = 0.012) and lower odds of giving birth to babies with birth weights (BWs) <2,500 g (DD = −11.8, ROR: 0.29, 95% CI: 0.10–0.82, p = 0.020). Positive effects were also found on women’s knowledge (DD = +14.8, ROR: 1.86, 95% CI: 1.32–2.62, p < 0.001) and physical IPV (DD = −7.9 pp, ROR: 0.60, 95% CI: 0.36–0.99, p = 0.048). Study limitations included the short evaluation period (24 months) and the low coverage of UCTs, which might have reduced the program’s impact. Conclusions UCTs targeting the first “1,000 days” had a protective effect on child’s linear growth in rural areas of Togo. Their simultaneous positive effects on various immediate, underlying, and basic causes of malnutrition certainly contributed to this ultimate impact. The positive impacts observed on pregnancy- and birth-related outcomes call for further attention to the conception period in nutrition-sensitive programs

    Evaluation de processus et impact nutritionnel d'un programme de transferts monétaires ciblant les femmes enceintes et les enfants de moins de deux ans en milieu rural au Togo : analyse d'un essai contrÎlé randomisé en clusters

    No full text
    Justification et objectifs : En 2014, le gouvernement du Togo a mis en place dans le nord du pays un programme pilote de transferts monĂ©taires (TM) qui consistait Ă  distribuer 8,40 USD/mois aux femmes pendant la pĂ©riode des "1000 jours" (de la conception jusqu'aux deux ans de l'enfant), combinĂ© Ă  des activitĂ©s de communication pour le changement de comportement (CCC). Nous avons menĂ© une Ă©valuation de processus et d'impact afin de savoir si ce programme pouvait amĂ©liorer la croissance des enfants, et en vue de documenter ses mĂ©canismes d'action. MĂ©thodologie : Le schĂ©ma d'Ă©valuation reposait sur une approche mixte, combinant mĂ©thodes quantitatives et qualitatives. L'impact a Ă©tĂ© Ă©valuĂ© par un essai contrĂŽlĂ© randomisĂ© en grappes, dans lequel 162 villages ont Ă©tĂ© alĂ©atoirement allouĂ©s Ă  un groupe intervention (TM + CCC) ou Ă  un groupe contrĂŽle (CCC). Dans chaque village, des Ă©chantillons reprĂ©sentatifs de couples mĂšre-enfant (ĂągĂ©s de 6-29 mois) ont Ă©tĂ© enquĂȘtĂ©s avant intervention (baseline, n=2658) et deux ans plus tard (endline, n=2031). La mĂ©thode de la double diffĂ©rence a Ă©tĂ© utilisĂ©e pour dĂ©terminer l'impact en intention-de-traiter sur les indicateurs primaires suivants : croissance linĂ©aire (indice taille-pour-Ăąge, HAZ), retard de croissance (HAZ<-2 Ă©cart-type) et petit poids de naissance (poids de naissance<2500g) ; ainsi que sur des indicateurs secondaires : sĂ©curitĂ© alimentaire du mĂ©nage, alimentation, santĂ© et accĂšs aux soins de la mĂšre et de l'enfant, hygiĂšne, connaissances et autonomie des mĂšres. Le fonctionnement du programme ainsi que son appropriation et utilisation par les bĂ©nĂ©ficiaires ont Ă©tĂ© Ă©valuĂ©s Ă  l'aide de 189 entretiens semi-directifs et 30 focus group menĂ©s auprĂšs des acteurs du programme, des femmes bĂ©nĂ©ficiaires et non-bĂ©nĂ©ficiaires. Des observations non participantes (n=40) des activitĂ©s du programme ont Ă©galement Ă©tĂ© menĂ©es. Une analyse thĂ©matique a Ă©tĂ© rĂ©alisĂ©e. RĂ©sultats : Le programme a connu d'importants problĂšmes de mise en oeuvre, en raison de son caractĂšre multisectoriel et de la complexitĂ© institutionnelle qui en dĂ©coulait. MalgrĂ© cela, le programme a eu un impact positif sur la croissance des jeunes enfants, sur le retard de croissance et sur la prĂ©valence du petit poids de naissance. L'impact sur le HAZ passait principalement par une diminution de la proportion des petits poids de naissance, ainsi que par deux voies d'impact : la voie « alimentation » (via la sĂ©curitĂ© alimentaire du mĂ©nage et la consommation de produits d'origine animale par l'enfant) et la voie "santĂ©" (via l'accĂšs aux soins prĂ© et postnatal et hygiĂšne maternelle). Les femmes dĂ©claraient utiliser le TM en faveur de l'enfant, grĂące Ă  une forte mobilisation et pression de la communautĂ©. Elles Ă©taient satisfaites de l'intervention qui leur permettait d'acquĂ©rir des connaissances puis de les mettre en pratique grĂące au TM. Des effets inattendus nĂ©gatifs ont Ă©tĂ© soulevĂ©s, tels que l'encouragement des naissances et la falsification des actes de naissance. Conclusions : Cette Ă©tude tĂ©moigne du potentiel des programmes de TM ciblant les "1000 jours" pour lutter contre la malnutrition et ses causes sous-jacentes. Elle a Ă©galement identifiĂ© certains mĂ©canismes d'action permettant d'orienter les interventions futures

    Matern Child Nutr

    No full text
    Adequate complementary feeding (CF) practices are essential for achieving optimal growth but challenging to measure comprehensively. This paper describes CF practices in 2034 children aged 6-23 months, and investigates their relationships with length-for-age z-score (LAZ) and stunting, using cross-sectional data collected from May to July 2014 in rural northern Togo. The WHO Infant and Young Child Feeding (IYCF) indicators were computed, along with ancillary indicators on feeding style and timing of introduction of complementary foods. The associations between those indicators and children's LAZ and stunting were assessed using linear and logistic regressions, after stratification by age group and adjustment for children, maternal and household characteristics. CF practices were suboptimal and their associations with child's growth varied across indicators and age groups. In children aged 6-11 months, reaching the Minimum Dietary Diversity and the Minimum Acceptable Diet was associated with higher LAZ (p<0.05). In 18-23 month-old children, only the consumption of iron-rich food was associated with both LAZ (p=0.02) and stunting (p=0.05). The late introduction of family foods was associated with higher odds of being stunted and lower LAZ in children aged 12-17 months (p<0.001). The untimely introduction of porridge was associated with higher odds of stunting in children aged 9-23 months (p<0.05). Unexpectedly, helping the child to eat was negatively associated with linear growth in all age groups. These findings nurture the ongoing process of review of the WHO IYCF indicators showing that, in their current version, they hardly capture the links between CF and child's growth at different ages

    Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition

    No full text
    The molecular mechanism of breast and/or ovarian cancer susceptibility remains unclear in the majority of patients. While germline mutations in the regulatory non-coding regions of BRCA1 and BRCA2 genes have been described, screening has generally been limited to coding regions. The aim of this study was to evaluate the contribution of BRCA1/2 non-coding variants.Four BRCA1/2 non-coding regions were screened using high-resolution melting analysis/Sanger sequencing or next-generation sequencing on DNA extracted from index cases with breast and ovarian cancer predisposition (3926 for BRCA1 and 3910 for BRCA2). The impact of a set of variants on BRCA1/2 gene regulation was evaluated by site-directed mutagenesis, transfection, followed by Luciferase gene reporter assay.We identified a total of 117 variants and tested twelve BRCA1 and 8 BRCA2 variants mapping to promoter and intronic regions. We highlighted two neighboring BRCA1 promoter variants (c.-130del; c.-125C\ua0>\ua0T) and one BRCA2 promoter variants (c.-296C\ua0>\ua0T) inhibiting significantly the promoter activity. In the functional assays, a regulating region within the intron 12 was found with the same enhancing impact as within the intron 2. Furthermore, the variants c.81-3980A\ua0>\ua0G and c.4186-2022C\ua0>\ua0T suppress the positive effect of the introns 2 and 12, respectively, on the BRCA1 promoter activity. We also found some variants inducing the promoter activities.In this study, we highlighted some variants among many, modulating negatively the promoter activity of BRCA1 or 2 and thus having a potential impact on the risk of developing cancer. This selection makes it possible to conduct future validation studies on a limited number of variants

    Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma

    No full text
    International audienceAnal squamous cell carcinomas (ASCC) are rare tumours in humans. The etiological role of HPV infection is now well established but little is known about the molecular landscape and signalling pathways involved in the pathogenesis of this cancer. Here we report the results from a whole exome sequencing of a homogeneous group of 20 treatment-naive ASCC. A total of 2422 somatic single nucleotide variations (SNV) were found, with an overall moderate rate of somatic mutations per tumour (median 105 relevant SNV per tumour) but a high mutational load in 3 tumours. The mutational signatures associated with age and APOBEC were observed in 100% and 60% of tumours respectively. The most frequently mutated genes were PIK3CA (25%) followed by FBXW7 (15%), FAT1 (15%), and TRIP12 (15%), the two last ones having never been described in ASCC. The main copy number alterations were gains of chromosome 3q (affecting PIK3CA) and losses of chromosome 11q (affecting ATM). The combined analysis of somatic mutations and copy number alterations show that recurrent alterations of the PI3K/AKT/mTOR pathway are frequent (60%) in these tumours, as well as potentially targetable alterations of other signalling pathways that have never been described in ASCC such as chromatin remodelling (45%) and ubiquitin mediated proteolysis (35%). These results highlight the possible implication of these aberrant signalling pathways in anal carcinogenesis and suggest promising new therapeutic approaches in ASCC. The high somatic mutation burden found in some tumours, suggesting an elevated neoantigen load could also predict sensitivity of ASCC to immunotherapy
    corecore